Advanced Medical Solutions Group (LON:AMS) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Shares of Advanced Medical Solutions Group plc (LON:AMS) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 216.47 and traded as low as GBX 215. Advanced Medical Solutions Group shares last traded at GBX 218, with a volume of 940,668 shares changing hands.

Wall Street Analysts Forecast Growth

AMS has been the topic of a number of recent research reports. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 260 target price on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Berenberg Bank reiterated a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a report on Tuesday, May 19th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Advanced Medical Solutions Group presently has an average rating of “Moderate Buy” and an average target price of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50. The stock has a 50-day simple moving average of GBX 221.68 and a 200-day simple moving average of GBX 216.47. The firm has a market capitalization of £475.04 million, a PE ratio of 48.45, a P/E/G ratio of 5.00 and a beta of 0.72.

Advanced Medical Solutions Group (LON:AMS) last released its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Analysts forecast that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.